Beckman CEO: Health reform to result in tiny gains for devices, tests
Overhauling the U.S. health care system to expand insurance coverage would result in surprisingly small increases in the demand for laboratory tests and medical devices of only 1% to 2% per year over the next 10 years because such a proposal would cover many young individuals who don't need regular treatment, said Beckman Coulter CEO Scott Garrett. Garrett said he hopes that a proposed tax on test and device makers would be lowered as lawmakers work to harmonize health reform measures in Congress.
Reuters | 11/09
This story published in AdvaMed SmartBrief on 11/16/2009
AdvaMed sets up group to lobby for diagnostics industry
Monday, December 28, 2009
Failed reform could lead to health-industry consolidation, analysts say
Tuesday, February 9, 2010
HHS report explains state-by-state impact of health overhaul
Tuesday, November 24, 2009
|
AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more |
|